Global Sex Hormones- Market

Sex Hormones- Comprehensive Study by Type (Progesterone, Testosterone, Drospirenone), Application (Topical, Inhalation, Injection, Others) Players and Region - Global Market Outlook to 2027

Sex Hormones- Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Sex hormones influence a broad spectrum of normal and abnormal neurological functions. Relationships between endogenous and exogenous sex hormones and many neurological conditions, such as migraine, stroke, and chorea, are well established. Sex hormones influence neuronal excitability, depending on the hormone type or its metabolite. The increasing involvement of key players in the development of novel therapies is resulting in the introduction of new products in the market. For instance. Increasing awareness about hormone deficiency and disorders is expected to propel market growth.

The Global Sex Hormones- market presents a comprehensive analysis of the Sex Hormones- market by product type (Progesterone, Testosterone and Drospirenone), by end-user/application (Topical, Inhalation, Injection and Others), and by geography (North America, South America, Europe, Asia-Pacific and MEA) along with country level break-up. The key Players profiled in the report are Pfizer (United States), Novartis (Switzerland), Merck (United States), Sanofi (France), Bayer (Germany), GSK (United Kingdom), AstraZeneca (United Kingdom), Cipla (India), Zizhu Pharma (China), Eli Lilly and Company (United States) and Novo Nordisk A/S (Denmark).

AttributesDetails
Study Period2017-2027
Base Year2021
Forecast Period-2027
Historical Period2017-2021
UnitValue (USD Million)
Key Companies ProfiledPfizer (United States), Novartis (Switzerland), Merck (United States), Sanofi (France), Bayer (Germany), GSK (United Kingdom), AstraZeneca (United Kingdom), Cipla (India), Zizhu Pharma (China), Eli Lilly and Company (United States) and Novo Nordisk A/S (Denmark)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Sex Hormones- Market Dynamics:
AttributesDetails
Growth Drivers
  • Increase in the Number of Women Suffering from Menopause
  • Surge in Global Parathyroid Hormone Replacement Segment is Witnessing the Growth
  • Increase in the Number of Male Population Tends to have a more Severe Infection and Higher rates of Hospitalization and Mortality
Influencing Trends
  • Launching of new long-acting Growth Hormone injection.
  • Increasing Research and Technological Development and Innovation for Novel Therapies
Restraints
  • Lack of Awareness of Hormone Deficiency and Disorders is Hampering the growth
Road Blocks / Challenges
  • Challenge to Improve in Drug Delivery Through Parenteral Modes
Gaps & Opportunities
  • Increasing Government Initiatives and Funding for the Development of Next-Generation Long-Acting Hormone Injection
  • Rising Healthcare Expenditure in Hypoparathyroidism Segment
  • Increased Hormone Replacement Therapy in North America


Regional Breakdown and Segment Analysis
This section of our report presents a realistic picture of the Global Sex Hormones- industry. Investors and manufacturers can easily understand the inherent opportunities and challenges for their products in the geographical region of interest.

The rising number of players expected to enter the global market is predicted to enhance the competition level as well as encourage the growth of the overall market in the near future. Players are anticipated to focus on the development of new compounds, which is likely to encourage the growth of the global market throughout the forecast period.
The regional segmentation covered in this report are:
South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)

Report Objectives / Segmentation Covered

By Type
  • Progesterone
  • Testosterone
  • Drospirenone
By Application
  • Topical
  • Inhalation
  • Injection
  • Others
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase in the Number of Women Suffering from Menopause
      • 3.2.2. Surge in Global Parathyroid Hormone Replacement Segment is Witnessing the Growth
      • 3.2.3. Increase in the Number of Male Population Tends to have a more Severe Infection and Higher rates of Hospitalization and Mortality
    • 3.3. Market Challenges
      • 3.3.1. Challenge to Improve in Drug Delivery Through Parenteral Modes
    • 3.4. Market Trends
      • 3.4.1. Launching of new long-acting Growth Hormone injection.
      • 3.4.2. Increasing Research and Technological Development and Innovation for Novel Therapies
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Sex Hormones-, by Type, Application and Region (value, volume and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Sex Hormones- (Value)
      • 5.2.1. Global Sex Hormones- by: Type (Value)
        • 5.2.1.1. Progesterone
        • 5.2.1.2. Testosterone
        • 5.2.1.3. Drospirenone
      • 5.2.2. Global Sex Hormones- by: Application (Value)
        • 5.2.2.1. Topical
        • 5.2.2.2. Inhalation
        • 5.2.2.3. Injection
        • 5.2.2.4. Others
      • 5.2.3. Global Sex Hormones- Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Australia
          • 5.2.3.2.6. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Sex Hormones- (Volume)
      • 5.3.1. Global Sex Hormones- by: Type (Volume)
        • 5.3.1.1. Progesterone
        • 5.3.1.2. Testosterone
        • 5.3.1.3. Drospirenone
      • 5.3.2. Global Sex Hormones- by: Application (Volume)
        • 5.3.2.1. Topical
        • 5.3.2.2. Inhalation
        • 5.3.2.3. Injection
        • 5.3.2.4. Others
      • 5.3.3. Global Sex Hormones- Region
        • 5.3.3.1. South America
          • 5.3.3.1.1. Brazil
          • 5.3.3.1.2. Argentina
          • 5.3.3.1.3. Rest of South America
        • 5.3.3.2. Asia Pacific
          • 5.3.3.2.1. China
          • 5.3.3.2.2. Japan
          • 5.3.3.2.3. India
          • 5.3.3.2.4. South Korea
          • 5.3.3.2.5. Australia
          • 5.3.3.2.6. Rest of Asia-Pacific
        • 5.3.3.3. Europe
          • 5.3.3.3.1. Germany
          • 5.3.3.3.2. France
          • 5.3.3.3.3. Italy
          • 5.3.3.3.4. United Kingdom
          • 5.3.3.3.5. Netherlands
          • 5.3.3.3.6. Rest of Europe
        • 5.3.3.4. MEA
          • 5.3.3.4.1. Middle East
          • 5.3.3.4.2. Africa
        • 5.3.3.5. North America
          • 5.3.3.5.1. United States
          • 5.3.3.5.2. Canada
          • 5.3.3.5.3. Mexico
    • 5.4. Global Sex Hormones- (Price)
      • 5.4.1. Global Sex Hormones- by: Type (Price)
  • 6. Sex Hormones-: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Pfizer (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Novartis (Switzerland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Merck (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Sanofi (France)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Bayer (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. GSK (United Kingdom)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. AstraZeneca (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Cipla (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Zizhu Pharma (China)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Eli Lilly and Company (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Novo Nordisk A/S (Denmark)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Sex Hormones- Sale, by Type, Application and Region (value, volume and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Sex Hormones- (Value)
      • 7.2.1. Global Sex Hormones- by: Type (Value)
        • 7.2.1.1. Progesterone
        • 7.2.1.2. Testosterone
        • 7.2.1.3. Drospirenone
      • 7.2.2. Global Sex Hormones- by: Application (Value)
        • 7.2.2.1. Topical
        • 7.2.2.2. Inhalation
        • 7.2.2.3. Injection
        • 7.2.2.4. Others
      • 7.2.3. Global Sex Hormones- Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Australia
          • 7.2.3.2.6. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Sex Hormones- (Volume)
      • 7.3.1. Global Sex Hormones- by: Type (Volume)
        • 7.3.1.1. Progesterone
        • 7.3.1.2. Testosterone
        • 7.3.1.3. Drospirenone
      • 7.3.2. Global Sex Hormones- by: Application (Volume)
        • 7.3.2.1. Topical
        • 7.3.2.2. Inhalation
        • 7.3.2.3. Injection
        • 7.3.2.4. Others
      • 7.3.3. Global Sex Hormones- Region
        • 7.3.3.1. South America
          • 7.3.3.1.1. Brazil
          • 7.3.3.1.2. Argentina
          • 7.3.3.1.3. Rest of South America
        • 7.3.3.2. Asia Pacific
          • 7.3.3.2.1. China
          • 7.3.3.2.2. Japan
          • 7.3.3.2.3. India
          • 7.3.3.2.4. South Korea
          • 7.3.3.2.5. Australia
          • 7.3.3.2.6. Rest of Asia-Pacific
        • 7.3.3.3. Europe
          • 7.3.3.3.1. Germany
          • 7.3.3.3.2. France
          • 7.3.3.3.3. Italy
          • 7.3.3.3.4. United Kingdom
          • 7.3.3.3.5. Netherlands
          • 7.3.3.3.6. Rest of Europe
        • 7.3.3.4. MEA
          • 7.3.3.4.1. Middle East
          • 7.3.3.4.2. Africa
        • 7.3.3.5. North America
          • 7.3.3.5.1. United States
          • 7.3.3.5.2. Canada
          • 7.3.3.5.3. Mexico
    • 7.4. Global Sex Hormones- (Price)
      • 7.4.1. Global Sex Hormones- by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Sex Hormones-: by Type(USD Million)
  • Table 2. Sex Hormones- Progesterone , by Region USD Million (2016-2021)
  • Table 3. Sex Hormones- Testosterone , by Region USD Million (2016-2021)
  • Table 4. Sex Hormones- Drospirenone , by Region USD Million (2016-2021)
  • Table 5. Sex Hormones-: by Application(USD Million)
  • Table 6. Sex Hormones- Topical , by Region USD Million (2016-2021)
  • Table 7. Sex Hormones- Inhalation , by Region USD Million (2016-2021)
  • Table 8. Sex Hormones- Injection , by Region USD Million (2016-2021)
  • Table 9. Sex Hormones- Others , by Region USD Million (2016-2021)
  • Table 10. South America Sex Hormones-, by Country USD Million (2016-2021)
  • Table 11. South America Sex Hormones-, by Type USD Million (2016-2021)
  • Table 12. South America Sex Hormones-, by Application USD Million (2016-2021)
  • Table 13. Brazil Sex Hormones-, by Type USD Million (2016-2021)
  • Table 14. Brazil Sex Hormones-, by Application USD Million (2016-2021)
  • Table 15. Argentina Sex Hormones-, by Type USD Million (2016-2021)
  • Table 16. Argentina Sex Hormones-, by Application USD Million (2016-2021)
  • Table 17. Rest of South America Sex Hormones-, by Type USD Million (2016-2021)
  • Table 18. Rest of South America Sex Hormones-, by Application USD Million (2016-2021)
  • Table 19. Asia Pacific Sex Hormones-, by Country USD Million (2016-2021)
  • Table 20. Asia Pacific Sex Hormones-, by Type USD Million (2016-2021)
  • Table 21. Asia Pacific Sex Hormones-, by Application USD Million (2016-2021)
  • Table 22. China Sex Hormones-, by Type USD Million (2016-2021)
  • Table 23. China Sex Hormones-, by Application USD Million (2016-2021)
  • Table 24. Japan Sex Hormones-, by Type USD Million (2016-2021)
  • Table 25. Japan Sex Hormones-, by Application USD Million (2016-2021)
  • Table 26. India Sex Hormones-, by Type USD Million (2016-2021)
  • Table 27. India Sex Hormones-, by Application USD Million (2016-2021)
  • Table 28. South Korea Sex Hormones-, by Type USD Million (2016-2021)
  • Table 29. South Korea Sex Hormones-, by Application USD Million (2016-2021)
  • Table 30. Australia Sex Hormones-, by Type USD Million (2016-2021)
  • Table 31. Australia Sex Hormones-, by Application USD Million (2016-2021)
  • Table 32. Rest of Asia-Pacific Sex Hormones-, by Type USD Million (2016-2021)
  • Table 33. Rest of Asia-Pacific Sex Hormones-, by Application USD Million (2016-2021)
  • Table 34. Europe Sex Hormones-, by Country USD Million (2016-2021)
  • Table 35. Europe Sex Hormones-, by Type USD Million (2016-2021)
  • Table 36. Europe Sex Hormones-, by Application USD Million (2016-2021)
  • Table 37. Germany Sex Hormones-, by Type USD Million (2016-2021)
  • Table 38. Germany Sex Hormones-, by Application USD Million (2016-2021)
  • Table 39. France Sex Hormones-, by Type USD Million (2016-2021)
  • Table 40. France Sex Hormones-, by Application USD Million (2016-2021)
  • Table 41. Italy Sex Hormones-, by Type USD Million (2016-2021)
  • Table 42. Italy Sex Hormones-, by Application USD Million (2016-2021)
  • Table 43. United Kingdom Sex Hormones-, by Type USD Million (2016-2021)
  • Table 44. United Kingdom Sex Hormones-, by Application USD Million (2016-2021)
  • Table 45. Netherlands Sex Hormones-, by Type USD Million (2016-2021)
  • Table 46. Netherlands Sex Hormones-, by Application USD Million (2016-2021)
  • Table 47. Rest of Europe Sex Hormones-, by Type USD Million (2016-2021)
  • Table 48. Rest of Europe Sex Hormones-, by Application USD Million (2016-2021)
  • Table 49. MEA Sex Hormones-, by Country USD Million (2016-2021)
  • Table 50. MEA Sex Hormones-, by Type USD Million (2016-2021)
  • Table 51. MEA Sex Hormones-, by Application USD Million (2016-2021)
  • Table 52. Middle East Sex Hormones-, by Type USD Million (2016-2021)
  • Table 53. Middle East Sex Hormones-, by Application USD Million (2016-2021)
  • Table 54. Africa Sex Hormones-, by Type USD Million (2016-2021)
  • Table 55. Africa Sex Hormones-, by Application USD Million (2016-2021)
  • Table 56. North America Sex Hormones-, by Country USD Million (2016-2021)
  • Table 57. North America Sex Hormones-, by Type USD Million (2016-2021)
  • Table 58. North America Sex Hormones-, by Application USD Million (2016-2021)
  • Table 59. United States Sex Hormones-, by Type USD Million (2016-2021)
  • Table 60. United States Sex Hormones-, by Application USD Million (2016-2021)
  • Table 61. Canada Sex Hormones-, by Type USD Million (2016-2021)
  • Table 62. Canada Sex Hormones-, by Application USD Million (2016-2021)
  • Table 63. Mexico Sex Hormones-, by Type USD Million (2016-2021)
  • Table 64. Mexico Sex Hormones-, by Application USD Million (2016-2021)
  • Table 65. Sex Hormones- Sales: by Type(N)
  • Table 66. Sex Hormones- Sales Progesterone , by Region N (2016-2021)
  • Table 67. Sex Hormones- Sales Testosterone , by Region N (2016-2021)
  • Table 68. Sex Hormones- Sales Drospirenone , by Region N (2016-2021)
  • Table 69. Sex Hormones- Sales: by Application(N)
  • Table 70. Sex Hormones- Sales Topical , by Region N (2016-2021)
  • Table 71. Sex Hormones- Sales Inhalation , by Region N (2016-2021)
  • Table 72. Sex Hormones- Sales Injection , by Region N (2016-2021)
  • Table 73. Sex Hormones- Sales Others , by Region N (2016-2021)
  • Table 74. South America Sex Hormones- Sales, by Country N (2016-2021)
  • Table 75. South America Sex Hormones- Sales, by Type N (2016-2021)
  • Table 76. South America Sex Hormones- Sales, by Application N (2016-2021)
  • Table 77. Brazil Sex Hormones- Sales, by Type N (2016-2021)
  • Table 78. Brazil Sex Hormones- Sales, by Application N (2016-2021)
  • Table 79. Argentina Sex Hormones- Sales, by Type N (2016-2021)
  • Table 80. Argentina Sex Hormones- Sales, by Application N (2016-2021)
  • Table 81. Rest of South America Sex Hormones- Sales, by Type N (2016-2021)
  • Table 82. Rest of South America Sex Hormones- Sales, by Application N (2016-2021)
  • Table 83. Asia Pacific Sex Hormones- Sales, by Country N (2016-2021)
  • Table 84. Asia Pacific Sex Hormones- Sales, by Type N (2016-2021)
  • Table 85. Asia Pacific Sex Hormones- Sales, by Application N (2016-2021)
  • Table 86. China Sex Hormones- Sales, by Type N (2016-2021)
  • Table 87. China Sex Hormones- Sales, by Application N (2016-2021)
  • Table 88. Japan Sex Hormones- Sales, by Type N (2016-2021)
  • Table 89. Japan Sex Hormones- Sales, by Application N (2016-2021)
  • Table 90. India Sex Hormones- Sales, by Type N (2016-2021)
  • Table 91. India Sex Hormones- Sales, by Application N (2016-2021)
  • Table 92. South Korea Sex Hormones- Sales, by Type N (2016-2021)
  • Table 93. South Korea Sex Hormones- Sales, by Application N (2016-2021)
  • Table 94. Australia Sex Hormones- Sales, by Type N (2016-2021)
  • Table 95. Australia Sex Hormones- Sales, by Application N (2016-2021)
  • Table 96. Rest of Asia-Pacific Sex Hormones- Sales, by Type N (2016-2021)
  • Table 97. Rest of Asia-Pacific Sex Hormones- Sales, by Application N (2016-2021)
  • Table 98. Europe Sex Hormones- Sales, by Country N (2016-2021)
  • Table 99. Europe Sex Hormones- Sales, by Type N (2016-2021)
  • Table 100. Europe Sex Hormones- Sales, by Application N (2016-2021)
  • Table 101. Germany Sex Hormones- Sales, by Type N (2016-2021)
  • Table 102. Germany Sex Hormones- Sales, by Application N (2016-2021)
  • Table 103. France Sex Hormones- Sales, by Type N (2016-2021)
  • Table 104. France Sex Hormones- Sales, by Application N (2016-2021)
  • Table 105. Italy Sex Hormones- Sales, by Type N (2016-2021)
  • Table 106. Italy Sex Hormones- Sales, by Application N (2016-2021)
  • Table 107. United Kingdom Sex Hormones- Sales, by Type N (2016-2021)
  • Table 108. United Kingdom Sex Hormones- Sales, by Application N (2016-2021)
  • Table 109. Netherlands Sex Hormones- Sales, by Type N (2016-2021)
  • Table 110. Netherlands Sex Hormones- Sales, by Application N (2016-2021)
  • Table 111. Rest of Europe Sex Hormones- Sales, by Type N (2016-2021)
  • Table 112. Rest of Europe Sex Hormones- Sales, by Application N (2016-2021)
  • Table 113. MEA Sex Hormones- Sales, by Country N (2016-2021)
  • Table 114. MEA Sex Hormones- Sales, by Type N (2016-2021)
  • Table 115. MEA Sex Hormones- Sales, by Application N (2016-2021)
  • Table 116. Middle East Sex Hormones- Sales, by Type N (2016-2021)
  • Table 117. Middle East Sex Hormones- Sales, by Application N (2016-2021)
  • Table 118. Africa Sex Hormones- Sales, by Type N (2016-2021)
  • Table 119. Africa Sex Hormones- Sales, by Application N (2016-2021)
  • Table 120. North America Sex Hormones- Sales, by Country N (2016-2021)
  • Table 121. North America Sex Hormones- Sales, by Type N (2016-2021)
  • Table 122. North America Sex Hormones- Sales, by Application N (2016-2021)
  • Table 123. United States Sex Hormones- Sales, by Type N (2016-2021)
  • Table 124. United States Sex Hormones- Sales, by Application N (2016-2021)
  • Table 125. Canada Sex Hormones- Sales, by Type N (2016-2021)
  • Table 126. Canada Sex Hormones- Sales, by Application N (2016-2021)
  • Table 127. Mexico Sex Hormones- Sales, by Type N (2016-2021)
  • Table 128. Mexico Sex Hormones- Sales, by Application N (2016-2021)
  • Table 129. Sex Hormones-: by Type(USD/Units)
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Sex Hormones-: by Type(USD Million)
  • Table 142. Sex Hormones- Progesterone , by Region USD Million (2022-2027)
  • Table 143. Sex Hormones- Testosterone , by Region USD Million (2022-2027)
  • Table 144. Sex Hormones- Drospirenone , by Region USD Million (2022-2027)
  • Table 145. Sex Hormones-: by Application(USD Million)
  • Table 146. Sex Hormones- Topical , by Region USD Million (2022-2027)
  • Table 147. Sex Hormones- Inhalation , by Region USD Million (2022-2027)
  • Table 148. Sex Hormones- Injection , by Region USD Million (2022-2027)
  • Table 149. Sex Hormones- Others , by Region USD Million (2022-2027)
  • Table 150. South America Sex Hormones-, by Country USD Million (2022-2027)
  • Table 151. South America Sex Hormones-, by Type USD Million (2022-2027)
  • Table 152. South America Sex Hormones-, by Application USD Million (2022-2027)
  • Table 153. Brazil Sex Hormones-, by Type USD Million (2022-2027)
  • Table 154. Brazil Sex Hormones-, by Application USD Million (2022-2027)
  • Table 155. Argentina Sex Hormones-, by Type USD Million (2022-2027)
  • Table 156. Argentina Sex Hormones-, by Application USD Million (2022-2027)
  • Table 157. Rest of South America Sex Hormones-, by Type USD Million (2022-2027)
  • Table 158. Rest of South America Sex Hormones-, by Application USD Million (2022-2027)
  • Table 159. Asia Pacific Sex Hormones-, by Country USD Million (2022-2027)
  • Table 160. Asia Pacific Sex Hormones-, by Type USD Million (2022-2027)
  • Table 161. Asia Pacific Sex Hormones-, by Application USD Million (2022-2027)
  • Table 162. China Sex Hormones-, by Type USD Million (2022-2027)
  • Table 163. China Sex Hormones-, by Application USD Million (2022-2027)
  • Table 164. Japan Sex Hormones-, by Type USD Million (2022-2027)
  • Table 165. Japan Sex Hormones-, by Application USD Million (2022-2027)
  • Table 166. India Sex Hormones-, by Type USD Million (2022-2027)
  • Table 167. India Sex Hormones-, by Application USD Million (2022-2027)
  • Table 168. South Korea Sex Hormones-, by Type USD Million (2022-2027)
  • Table 169. South Korea Sex Hormones-, by Application USD Million (2022-2027)
  • Table 170. Australia Sex Hormones-, by Type USD Million (2022-2027)
  • Table 171. Australia Sex Hormones-, by Application USD Million (2022-2027)
  • Table 172. Rest of Asia-Pacific Sex Hormones-, by Type USD Million (2022-2027)
  • Table 173. Rest of Asia-Pacific Sex Hormones-, by Application USD Million (2022-2027)
  • Table 174. Europe Sex Hormones-, by Country USD Million (2022-2027)
  • Table 175. Europe Sex Hormones-, by Type USD Million (2022-2027)
  • Table 176. Europe Sex Hormones-, by Application USD Million (2022-2027)
  • Table 177. Germany Sex Hormones-, by Type USD Million (2022-2027)
  • Table 178. Germany Sex Hormones-, by Application USD Million (2022-2027)
  • Table 179. France Sex Hormones-, by Type USD Million (2022-2027)
  • Table 180. France Sex Hormones-, by Application USD Million (2022-2027)
  • Table 181. Italy Sex Hormones-, by Type USD Million (2022-2027)
  • Table 182. Italy Sex Hormones-, by Application USD Million (2022-2027)
  • Table 183. United Kingdom Sex Hormones-, by Type USD Million (2022-2027)
  • Table 184. United Kingdom Sex Hormones-, by Application USD Million (2022-2027)
  • Table 185. Netherlands Sex Hormones-, by Type USD Million (2022-2027)
  • Table 186. Netherlands Sex Hormones-, by Application USD Million (2022-2027)
  • Table 187. Rest of Europe Sex Hormones-, by Type USD Million (2022-2027)
  • Table 188. Rest of Europe Sex Hormones-, by Application USD Million (2022-2027)
  • Table 189. MEA Sex Hormones-, by Country USD Million (2022-2027)
  • Table 190. MEA Sex Hormones-, by Type USD Million (2022-2027)
  • Table 191. MEA Sex Hormones-, by Application USD Million (2022-2027)
  • Table 192. Middle East Sex Hormones-, by Type USD Million (2022-2027)
  • Table 193. Middle East Sex Hormones-, by Application USD Million (2022-2027)
  • Table 194. Africa Sex Hormones-, by Type USD Million (2022-2027)
  • Table 195. Africa Sex Hormones-, by Application USD Million (2022-2027)
  • Table 196. North America Sex Hormones-, by Country USD Million (2022-2027)
  • Table 197. North America Sex Hormones-, by Type USD Million (2022-2027)
  • Table 198. North America Sex Hormones-, by Application USD Million (2022-2027)
  • Table 199. United States Sex Hormones-, by Type USD Million (2022-2027)
  • Table 200. United States Sex Hormones-, by Application USD Million (2022-2027)
  • Table 201. Canada Sex Hormones-, by Type USD Million (2022-2027)
  • Table 202. Canada Sex Hormones-, by Application USD Million (2022-2027)
  • Table 203. Mexico Sex Hormones-, by Type USD Million (2022-2027)
  • Table 204. Mexico Sex Hormones-, by Application USD Million (2022-2027)
  • Table 205. Sex Hormones- Sales: by Type(N)
  • Table 206. Sex Hormones- Sales Progesterone , by Region N (2022-2027)
  • Table 207. Sex Hormones- Sales Testosterone , by Region N (2022-2027)
  • Table 208. Sex Hormones- Sales Drospirenone , by Region N (2022-2027)
  • Table 209. Sex Hormones- Sales: by Application(N)
  • Table 210. Sex Hormones- Sales Topical , by Region N (2022-2027)
  • Table 211. Sex Hormones- Sales Inhalation , by Region N (2022-2027)
  • Table 212. Sex Hormones- Sales Injection , by Region N (2022-2027)
  • Table 213. Sex Hormones- Sales Others , by Region N (2022-2027)
  • Table 214. South America Sex Hormones- Sales, by Country N (2022-2027)
  • Table 215. South America Sex Hormones- Sales, by Type N (2022-2027)
  • Table 216. South America Sex Hormones- Sales, by Application N (2022-2027)
  • Table 217. Brazil Sex Hormones- Sales, by Type N (2022-2027)
  • Table 218. Brazil Sex Hormones- Sales, by Application N (2022-2027)
  • Table 219. Argentina Sex Hormones- Sales, by Type N (2022-2027)
  • Table 220. Argentina Sex Hormones- Sales, by Application N (2022-2027)
  • Table 221. Rest of South America Sex Hormones- Sales, by Type N (2022-2027)
  • Table 222. Rest of South America Sex Hormones- Sales, by Application N (2022-2027)
  • Table 223. Asia Pacific Sex Hormones- Sales, by Country N (2022-2027)
  • Table 224. Asia Pacific Sex Hormones- Sales, by Type N (2022-2027)
  • Table 225. Asia Pacific Sex Hormones- Sales, by Application N (2022-2027)
  • Table 226. China Sex Hormones- Sales, by Type N (2022-2027)
  • Table 227. China Sex Hormones- Sales, by Application N (2022-2027)
  • Table 228. Japan Sex Hormones- Sales, by Type N (2022-2027)
  • Table 229. Japan Sex Hormones- Sales, by Application N (2022-2027)
  • Table 230. India Sex Hormones- Sales, by Type N (2022-2027)
  • Table 231. India Sex Hormones- Sales, by Application N (2022-2027)
  • Table 232. South Korea Sex Hormones- Sales, by Type N (2022-2027)
  • Table 233. South Korea Sex Hormones- Sales, by Application N (2022-2027)
  • Table 234. Australia Sex Hormones- Sales, by Type N (2022-2027)
  • Table 235. Australia Sex Hormones- Sales, by Application N (2022-2027)
  • Table 236. Rest of Asia-Pacific Sex Hormones- Sales, by Type N (2022-2027)
  • Table 237. Rest of Asia-Pacific Sex Hormones- Sales, by Application N (2022-2027)
  • Table 238. Europe Sex Hormones- Sales, by Country N (2022-2027)
  • Table 239. Europe Sex Hormones- Sales, by Type N (2022-2027)
  • Table 240. Europe Sex Hormones- Sales, by Application N (2022-2027)
  • Table 241. Germany Sex Hormones- Sales, by Type N (2022-2027)
  • Table 242. Germany Sex Hormones- Sales, by Application N (2022-2027)
  • Table 243. France Sex Hormones- Sales, by Type N (2022-2027)
  • Table 244. France Sex Hormones- Sales, by Application N (2022-2027)
  • Table 245. Italy Sex Hormones- Sales, by Type N (2022-2027)
  • Table 246. Italy Sex Hormones- Sales, by Application N (2022-2027)
  • Table 247. United Kingdom Sex Hormones- Sales, by Type N (2022-2027)
  • Table 248. United Kingdom Sex Hormones- Sales, by Application N (2022-2027)
  • Table 249. Netherlands Sex Hormones- Sales, by Type N (2022-2027)
  • Table 250. Netherlands Sex Hormones- Sales, by Application N (2022-2027)
  • Table 251. Rest of Europe Sex Hormones- Sales, by Type N (2022-2027)
  • Table 252. Rest of Europe Sex Hormones- Sales, by Application N (2022-2027)
  • Table 253. MEA Sex Hormones- Sales, by Country N (2022-2027)
  • Table 254. MEA Sex Hormones- Sales, by Type N (2022-2027)
  • Table 255. MEA Sex Hormones- Sales, by Application N (2022-2027)
  • Table 256. Middle East Sex Hormones- Sales, by Type N (2022-2027)
  • Table 257. Middle East Sex Hormones- Sales, by Application N (2022-2027)
  • Table 258. Africa Sex Hormones- Sales, by Type N (2022-2027)
  • Table 259. Africa Sex Hormones- Sales, by Application N (2022-2027)
  • Table 260. North America Sex Hormones- Sales, by Country N (2022-2027)
  • Table 261. North America Sex Hormones- Sales, by Type N (2022-2027)
  • Table 262. North America Sex Hormones- Sales, by Application N (2022-2027)
  • Table 263. United States Sex Hormones- Sales, by Type N (2022-2027)
  • Table 264. United States Sex Hormones- Sales, by Application N (2022-2027)
  • Table 265. Canada Sex Hormones- Sales, by Type N (2022-2027)
  • Table 266. Canada Sex Hormones- Sales, by Application N (2022-2027)
  • Table 267. Mexico Sex Hormones- Sales, by Type N (2022-2027)
  • Table 268. Mexico Sex Hormones- Sales, by Application N (2022-2027)
  • Table 269. Sex Hormones-: by Type(USD/Units)
  • Table 270. Research Programs/Design for This Report
  • Table 271. Key Data Information from Secondary Sources
  • Table 272. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Sex Hormones-: by Type USD Million (2016-2021)
  • Figure 5. Global Sex Hormones-: by Application USD Million (2016-2021)
  • Figure 6. South America Sex Hormones- Share (%), by Country
  • Figure 7. Asia Pacific Sex Hormones- Share (%), by Country
  • Figure 8. Europe Sex Hormones- Share (%), by Country
  • Figure 9. MEA Sex Hormones- Share (%), by Country
  • Figure 10. North America Sex Hormones- Share (%), by Country
  • Figure 11. Global Sex Hormones-: by Type N (2016-2021)
  • Figure 12. Global Sex Hormones-: by Application N (2016-2021)
  • Figure 13. South America Sex Hormones- Share (%), by Country
  • Figure 14. Asia Pacific Sex Hormones- Share (%), by Country
  • Figure 15. Europe Sex Hormones- Share (%), by Country
  • Figure 16. MEA Sex Hormones- Share (%), by Country
  • Figure 17. North America Sex Hormones- Share (%), by Country
  • Figure 18. Global Sex Hormones-: by Type USD/Units (2016-2021)
  • Figure 19. Global Sex Hormones- share by Players 2021 (%)
  • Figure 20. Global Sex Hormones- share by Players (Top 3) 2021(%)
  • Figure 21. Global Sex Hormones- share by Players (Top 5) 2021(%)
  • Figure 22. BCG Matrix for key Companies
  • Figure 23. Pfizer (United States) Revenue, Net Income and Gross profit
  • Figure 24. Pfizer (United States) Revenue: by Geography 2021
  • Figure 25. Novartis (Switzerland) Revenue, Net Income and Gross profit
  • Figure 26. Novartis (Switzerland) Revenue: by Geography 2021
  • Figure 27. Merck (United States) Revenue, Net Income and Gross profit
  • Figure 28. Merck (United States) Revenue: by Geography 2021
  • Figure 29. Sanofi (France) Revenue, Net Income and Gross profit
  • Figure 30. Sanofi (France) Revenue: by Geography 2021
  • Figure 31. Bayer (Germany) Revenue, Net Income and Gross profit
  • Figure 32. Bayer (Germany) Revenue: by Geography 2021
  • Figure 33. GSK (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 34. GSK (United Kingdom) Revenue: by Geography 2021
  • Figure 35. AstraZeneca (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 36. AstraZeneca (United Kingdom) Revenue: by Geography 2021
  • Figure 37. Cipla (India) Revenue, Net Income and Gross profit
  • Figure 38. Cipla (India) Revenue: by Geography 2021
  • Figure 39. Zizhu Pharma (China) Revenue, Net Income and Gross profit
  • Figure 40. Zizhu Pharma (China) Revenue: by Geography 2021
  • Figure 41. Eli Lilly and Company (United States) Revenue, Net Income and Gross profit
  • Figure 42. Eli Lilly and Company (United States) Revenue: by Geography 2021
  • Figure 43. Novo Nordisk A/S (Denmark) Revenue, Net Income and Gross profit
  • Figure 44. Novo Nordisk A/S (Denmark) Revenue: by Geography 2021
  • Figure 45. Global Sex Hormones-: by Type USD Million (2022-2027)
  • Figure 46. Global Sex Hormones-: by Application USD Million (2022-2027)
  • Figure 47. South America Sex Hormones- Share (%), by Country
  • Figure 48. Asia Pacific Sex Hormones- Share (%), by Country
  • Figure 49. Europe Sex Hormones- Share (%), by Country
  • Figure 50. MEA Sex Hormones- Share (%), by Country
  • Figure 51. North America Sex Hormones- Share (%), by Country
  • Figure 52. Global Sex Hormones-: by Type N (2022-2027)
  • Figure 53. Global Sex Hormones-: by Application N (2022-2027)
  • Figure 54. South America Sex Hormones- Share (%), by Country
  • Figure 55. Asia Pacific Sex Hormones- Share (%), by Country
  • Figure 56. Europe Sex Hormones- Share (%), by Country
  • Figure 57. MEA Sex Hormones- Share (%), by Country
  • Figure 58. North America Sex Hormones- Share (%), by Country
  • Figure 59. Global Sex Hormones-: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • Pfizer (United States)
  • Novartis (Switzerland)
  • Merck (United States)
  • Sanofi (France)
  • Bayer (Germany)
  • GSK (United Kingdom)
  • AstraZeneca (United Kingdom)
  • Cipla (India)
  • Zizhu Pharma (China)
  • Eli Lilly and Company (United States)
  • Novo Nordisk A/S (Denmark)
Select User Access Type

Key Highlights of Report


Aug 2022 217 Pages 91 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Sex Hormones- Market Quantitative research analysis
Global Sex Hormones- Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Global Sex Hormones- market is predicted to grow at a CAGR of % between 2021 - 2027.
Global Sex Hormones- market is restrained by Lack of Awareness of Hormone Deficiency and Disorders is Hampering the growth.
The Sex Hormones- market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get complete companies available in our research coverage.

Know More About Global Sex Hormones- Market Report?

Have a Query? Click Here

Other Related Reports

Machine Learning in Healthcare- Comprehensive Study by Type (Software Solutions, Hardware, Services), Application (Robot-Assisted Surgery, Virtual Assistants, Administrative Workflow Assistants, Conn...
$ 3800
Electroanatomical Cardiac Mapping Comprehensive Study by Type (Contact Cardiac, Non-Contact Cardiac), Indication (Atrial Fibrillation, Atrial Flutter, AVNRT, Other) Players and Region - Global Market...
$ 3800
Intelligent Hospital System - Comprehensive Study by Type (Appointment Management, Patient Management, Facility Management, Staff Management, Supply Management, Others), Application (Hospitals, Clini...
$ 3800
Next Generation Sequencing (NGS) Product Comprehensive Study by Type (NGS Consumables, Presequencing Products & Services, NGS Platforms, Bioinformatics, Others), Application (Oncology, Reproductive H...
$ 3800
Cardiac Marker Analyzers Comprehensive Study by Application (Hospital, Clinic), Types of Cardiac Markers (Troponin, Creatine kinase (CK), Myoblobin, Lactate dehydrogenase (LDH), C-reactive protein (C...
$ 3600
Clinical Data Management and Statistical Analysis Comprehensive Study by Technology (Cloud Computing, Blockchain, Artificial Intelligence, Machine Learning, Other), Service (Electronic Data Integrati...
$ 3800